Federal
Register Notices > Notices
of Application - 2001 > Isotec, Inc.
[Federal Register: April 6, 2001 (Volume 66, Number
67)]
[Notices]
[Page 18310]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06ap01-84]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of
Application
Pursuant to ยง
1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this
is notice that on November 22, 2000, Isotec, Inc., 3858 Benner Road,
Miamisburg, Ohio 45342, made application by renewal to the Drug
Enforcement Administration (DEA) for registration as a bulk manufacturer
of the basic classes of controlled substances listed below:
Drug |
Schedule |
Cathinone (1235) |
I |
Methcathinone (1237) |
I |
N-Ethylamphetamine (1475) |
I |
N,N-Dimethylamphetamine (1480) |
I |
Aminorex (1585) |
I |
Methaqualone (2565) |
I |
Lysergic acid diethylamide (7315) |
I |
Tetrahydrocannabinols (7370) |
I |
Mescaline (7381) |
I |
2,5-Dimethoxyamphetamine (7396) |
I |
3,4-methylenedioxyamphetamine
(7400) |
I |
3,4-Methylenedioxy-N-ethylamphetamine
(7404) |
I |
3,4-Methylenedioxymethamphetamine
(7405) |
I |
4-Methoxyamphetamine (7411) |
I |
Psilocybin (7437) |
I |
Psilocyn (7438) |
I |
N-Ethyl-1-phenylcyclohexylamine
(7455) |
I |
Dihydromorphine (9145) |
I |
Normorphine (9313) |
I |
Acetylmethadol (9601) |
I |
Alphacetylmethadol Except Levo- |
I |
Alphacetylmethadol (9603) |
I |
Normethadone (9635) |
I |
3-Methylfentanyl (9813) |
I |
Amphetamine (1100) |
II |
Methamphetamine (1105) |
II |
Methylphenidate (1724) |
II |
Amobarbital (2125) |
II |
Pentobarbital (2270) |
II |
Secobarbital (2315) |
II |
1-Phenylcyclohexylamine (7460) |
II |
Phencyclidine (7471) |
II |
Phenylacetone (8501) |
II |
1-Piperidinocyclohexanecarbonitrile
(8603) |
II |
Codeine (9050) |
II |
Dihydrocodeine (9120) |
II |
Oxycodone (9143) |
II |
Hydromorphone (9150) |
II |
Benzoylecgonine (9180) |
II |
Ethylmorphine (9190) |
II |
Hydrocodone (9193) |
II |
Isomethadone (9226) |
II |
Meperidine (9230) |
II |
Methadone (9250) |
II |
Methadone intermediate (9254) |
II |
Dextropropoxyphene, bulk
(non-dosage forms) (9273). |
II |
Morphine (9300) |
II |
Thebaine (9333) |
II |
Levo-Alphacetylmethadol (9648) |
II |
Oxymorphone (9652) |
II |
Fentanyl (9801) |
II |
The firm plans to manufacture small quantities of
the listed controlled substances to produce standards for analytical
laboratories.
Any other such applicant and any person who is
presently registered with DEA to manufacture such substances may file
comments or objections to the issuance of the proposed registration.
Any such comments or objections may be addressed, in
quintuplicate, to the Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration, United States Department of
Justice, Washington, DC 20537, Attention: DEA Federal Register
Representative (CCR), and must be filed no later than June 5, 2001.
Dated: March 29, 2001.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 01-8549 Filed 4-5-01; 8:45 am]
BILLING CODE 4410-09-M
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
Back to
Top
Registration
Support
Toll Free Number: 1-800-882-9539
ARCOS
| Career Opportunities | Chemical Program |
Controlled
Substance Schedules | Drugs and
Chemicals of Concern
Electronic Commerce Initiatives | | Federal Register
Notices | Import Export | Links
| Meetings
and Events | NFLIS
Offices &
Directories | On-Line Forms & Applications |
Program
Description | Publications
|
Questions & Answers | Quotas
Reports Required by 21 CFR | Title 21 Regulations & Codified
CSA
Contact Us | Home
| Hot
Items | Site Map | Search | What's New
|